Tauopathies, including Alzheimer’s disease (AD) and some forms of frontotemporal dementia (FTD), are characterised by heterogenous deposition of phosphorylated tau aggregates in different neural cell types and brain regions (Kovacs, 2020). The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.